BioLineRx (BLRX) Debt Ratio (2021 - 2025)

BioLineRx has reported Debt Ratio over the past 5 years, most recently at 0.22 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.22 for Q4 2025, down 36.73% from a year ago — trailing twelve months through Dec 2025 was 0.04 (down 21.24% YoY), and the annual figure for FY2025 was 0.22, down 36.73%.
  • Debt Ratio for Q4 2025 was 0.22 at BioLineRx, down from 0.35 in the prior quarter.
  • Over the last five years, Debt Ratio for BLRX hit a ceiling of 0.35 in Q4 2024 and a floor of 0.03 in Q4 2021.
  • Median Debt Ratio over the past 5 years was 0.15 (2023), compared with a mean of 0.18.
  • Biggest five-year swings in Debt Ratio: surged 292.98% in 2022 and later tumbled 36.73% in 2025.
  • BioLineRx's Debt Ratio stood at 0.03 in 2021, then surged by 292.98% to 0.13 in 2022, then rose by 14.85% to 0.15 in 2023, then soared by 125.91% to 0.35 in 2024, then tumbled by 36.73% to 0.22 in 2025.
  • The last three reported values for Debt Ratio were 0.22 (Q4 2025), 0.35 (Q4 2024), and 0.15 (Q4 2023) per Business Quant data.